Biennial screening mammography is cost effective in healthy women aged over 65 years

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations


Question. What is the cost-effectiveness of screening mammography in women over 65 years old? Study design. Systematic review with narrative synthesis. Main results. Ten studies, out of 115 identified, met inclusion criteria. Studies had similar cost-effectiveness findings; extending biennial screening to ages 75-80 years cost, on average, $34,000-$88,000 per life year gained compared with stopping screening at age 65 (adjusted to 2002 US dollars). Two studies found breast cancer screening less effective at reducing mortality in women with significant comorbidities (dementia, congestive heart failure, or hypertension), thus reducing the cost-effectiveness of screening in this population. No study fully adjusted for potential harms of screening. Authors' conclusions. In women aged over 65 years without serious comorbidity, biennial breast cancer screening reduces mortality at reasonable costs.

Original languageEnglish (US)
Pages (from-to)142-144
Number of pages3
JournalEvidence-Based Healthcare
Issue number3
StatePublished - Jun 2004
Externally publishedYes


  • Breast cancer
  • Cost-effectiveness
  • Elderly
  • Mammography
  • Mass screening
  • Systematic review

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Biennial screening mammography is cost effective in healthy women aged over 65 years'. Together they form a unique fingerprint.

Cite this